down arrow

Tianjin Tianyao Pharmaceuticals Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001840
  • SHG: 600488
CNY
6.13
-0.16 (-2.54%)

Sep 22

SHG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Tianjin Tianyao Pharmaceuticals Co., Ltd.

Why is Tianjin Tianyao Pharmaceuticals Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 4.51%
  • The company has been able to generate a Return on Capital Employed (avg) of 4.51% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
  • Poor long term growth as Net Sales has grown by an annual rate of -3.12% and Operating profit at -6.61% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 3.94% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -3.12% and Operating profit at -6.61% over the last 5 years
4
With ROE of 2.03%, it has a very expensive valuation with a 1.58 Price to Book Value
  • Over the past year, while the stock has generated a return of 51.20%, its profits have fallen by -70.7%
  • At the current price, the company has a high dividend yield of 0
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Tianjin Tianyao Pharmaceuticals Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Tianjin Tianyao Pharmaceuticals Co., Ltd.
48.43%
0.86
79.65%
China Shanghai Composite
3.23%
0.23
14.72%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-3.12%
EBIT Growth (5y)
-6.61%
EBIT to Interest (avg)
4.96
Debt to EBITDA (avg)
1.23
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.83
Tax Ratio
3.43%
Dividend Payout Ratio
80.50%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.46%
ROE (avg)
3.94%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
78
Industry P/E
Price to Book Value
1.58
EV to EBIT
39.60
EV to EBITDA
14.12
EV to Capital Employed
1.57
EV to Sales
1.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.96%
ROE (Latest)
2.03%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
CASH AND EQV(HY)

Highest at CNY 1,558.86 MM

DEBT-EQUITY RATIO (HY)

Lowest at -1.11 %

PRE-TAX PROFIT(Q)

Highest at CNY 45.99 MM

NET PROFIT(Q)

Highest at CNY 29.28 MM

EPS(Q)

Highest at CNY 0.03

-7What is not working for the Company
NET SALES(HY)

At CNY 1,313.06 MM has Grown at -17.33%

RAW MATERIAL COST(Y)

Grown by 5.68% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.54 times

Here's what is working for Tianjin Tianyao Pharmaceuticals Co., Ltd.

Net Profit
At CNY 29.28 MM has Grown at 343.58%
over average net sales of the previous four periods of CNY 6.6 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit
At CNY 45.99 MM has Grown at 179.91%
over average net sales of the previous four periods of CNY 16.43 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit
Highest at CNY 45.99 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 29.28 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.03
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 1,558.86 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -1.11 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Tianjin Tianyao Pharmaceuticals Co., Ltd.

Net Sales
At CNY 1,313.06 MM has Grown at -17.33%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CNY MM)

Debtors Turnover Ratio
Lowest at 3.54 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 5.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading